v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
 3 Months Ended
Mar. 29, 2026
Mar. 30, 2025
Cash flows from operating activities:    
Net earnings (loss) $ (5.9) $ 5.8
Adjustments to reconcile net earnings to net cash from operating activities:    
Asset impairment charge 2.2 0.0
Deferred income taxes 5.0 (0.8)
Depreciation and amortization 9.9 11.0
Operating lease asset amortization 2.6 2.6
Provision for credit losses and sales allowances 1.2 3.0
Stock-based compensation 3.4 3.7
Other, net 0.3 (0.3)
Changes in operating assets and liabilities    
Accounts receivable (26.3) 10.5
Other assets (4.5) 0.6
Accounts payable (7.3) (24.2)
Other liabilities (6.0) 12.0
Net cash (used in) from operating activities (25.4) 23.9
Cash flows from investing activities:    
Capital expenditures (1.1) (2.5)
Proceeds from sale of PersolKelly investment 0.0 6.4
Other investing activities (0.1) (0.7)
Net cash (used in) from investing activities (1.2) 3.2
Cash flows from financing activities:    
Proceeds from long-term debt 389.5 412.3
Payments on long-term debt (360.9) (447.1)
Dividend payments (2.7) (2.8)
Payments of tax withholding for stock awards (1.4) (1.8)
Other financing activities (0.3) (0.1)
Net cash from (used in) financing activities 24.2 (39.5)
Effect of exchange rates on cash, cash equivalents and restricted cash (5.8) 1.3
Net change in cash, cash equivalents and restricted cash (8.2) (11.1)
Cash, cash equivalents and restricted cash at beginning of period 37.7 45.6
Cash, cash equivalents and restricted cash at end of period 29.5 34.5
Cash and cash equivalents 25.6 28.2
Restricted cash included in prepaid expenses and other current assets 0.2 0.4
Restricted cash included in other assets $ 3.7 $ 5.9